title: [Use of etofibrate in the treatment of patients with hyperlipidemia and arteriosclerosis obliterans of the legs].
authors.forename: A
authors.initials: A
authors.lastname: Dembińska-Kieć
authors.forename: E
authors.initials: E
authors.lastname: Kostka-Trabka
authors.forename: L
authors.initials: L
authors.lastname: Grodzińska
authors.forename: K
authors.initials: K
authors.lastname: Bieroń
authors.forename: A
authors.initials: A
authors.lastname: Kedzior
authors.forename: M
authors.initials: M
authors.lastname: Basista
authors.forename: A
authors.initials: A
authors.lastname: Zmuda
authors.forename: E
authors.initials: E
authors.lastname: Trabka
authors.forename: M
authors.initials: M
authors.lastname: Sławiński
authors.forename: B
authors.initials: B
authors.lastname: Czarnecka
mesh_terms: D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D007866:Leg / Q000098:blood supply*; D008297:Male
chemical_list: C009746:etofibrate; D002995:Clofibric Acid; D002994:Clofibrate
vernacular_title: Zastosowanie etofibratu w leczeniu chorych z hiperlipidemia i zarostowa miazdzyca tetnic kończyn dolnych.